Literature DB >> 11175432

Fixed-ratio size as a determinant of the development of tolerance to morphine.

M. Nickel1, A. Poling.   

Abstract

The acute and chronic effects of morphine were examined in pigeons exposed to a multiple schedule with fixed-ratio 5, 25, and 125 components. Acute exposure to morphine (0.56-10.0 mg/kg) resulted in rate reductions under each component when the dose was 1 mg/kg or higher. With chronic exposure to 5.6 mg/kg, tolerance to the rate-reducing effects of morphine was evident under each fixed-ratio component. The development of tolerance was determined to some extent by fixed-ratio size, a result similar to earlier findings with cocaine.

Entities:  

Year:  1990        PMID: 11175432     DOI: 10.1097/00008877-199000150-00009

Source DB:  PubMed          Journal:  Behav Pharmacol        ISSN: 0955-8810            Impact factor:   2.293


  5 in total

1.  Tolerance to the effects of cocaine on performance under behavior-correlated reinforcement magnitude.

Authors:  M L Miller; G W Brodkorb; M N Branch
Journal:  J Exp Anal Behav       Date:  2001-09       Impact factor: 2.468

2.  Tolerance to effects of cocaine on behavior under a response-initiated fixed-interval schedule.

Authors:  Matthew T Weaver; Marc N Branch
Journal:  J Exp Anal Behav       Date:  2008-09       Impact factor: 2.468

3.  Tolerance to cocaine's effects following chronic administration of a dose without detected effects on response rate or pause.

Authors:  Vanessa Minervini; Marc N Branch
Journal:  J Exp Anal Behav       Date:  2013-09-09       Impact factor: 2.468

4.  Morphine tolerance as a function of ratio schedule: response requirement or unit price?

Authors:  Christine E Hughes; Stacey C Sigmon; Raymond C Pitts; Linda A Dykstra
Journal:  J Exp Anal Behav       Date:  2005-05       Impact factor: 2.468

5.  The effects of nicotine self-administration and withdrawal on concurrently available chow and sucrose intake in adult male rats.

Authors:  Patricia E Bunney; Danielle Burroughs; Christine Hernandez; Mark G LeSage
Journal:  Physiol Behav       Date:  2015-11-06
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.